
Journal of Pharmaceutical Sciences p. 471 - 477 (1984)
Update date:2022-08-04
Topics:
Dimmock
Shyam
Logan
Smith
Cross
A number of analogues of 3-dimethylamino-2-dimethylaminomethyl-1-(4-methoxyphenyl)-1-propanone dihydrochloride (IIa) and related compounds which showed activity against P388 lymphocytic leukemia were prepared, and of the 16 analogues, three met the criterion for activity in this screen. The toxicity of IIa was examined in rats and either single dose of 25 mg/kg or nine daily doses of 12.5 mg/kg administered by the intraperitoneal route produced marked irritation and damage to the tissue with which it came into contact. Compound IIa did not show significant activity against eight other tumor systems.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Contact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
NINGBO YINLIANG FOREIGN TRADE CO., LTD.
Contact:+86-574-87834016 / 87898057
Address:23F NO.666JINYU ROAD,YINGZHOU DISTRICT,NINGBO.CHINA
Zhongshan Haihong Medicine Co., Ltd.
Contact:86-0760-86925778 (0)18824993998
Address:A7 building,lianyuan road Torch Hi-tech Industrial Development Zone
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Doi:10.1021/jm060193m
(2006)Doi:10.1016/j.bmcl.2006.04.085
(2006)Doi:10.1002/hlca.201000463
(2011)Doi:10.1021/jacs.1c01951
(2021)Doi:10.1016/0040-4020(84)85098-X
(1984)Doi:10.1021/acs.joc.9b02453
(2019)